Sentence examples for medication acquisition cost from inspiring English sources

The medication acquisition cost of olanzapine and risperidone were estimated using the least expensive combination of average wholesale price doses.

A significant reduction in nonmedication health care costs was offset by the higher medication acquisition cost of olanzapine relative to generic risperidone.

For example, olanzapine had the highest annual medication acquisition cost but the lowest annual mean cost of treating relapse of the 5 comparators.

Thus, despite the significantly higher medication acquisition cost of olanzapine, the average daily antipsychotic medication cost was found to be significantly higher for quetiapine ($15.33) compared to olanzapine ($13.90) and risperidone ($11.04).

In the 1-year post initiation, the olanzapine group had an average of 280 days on olanzapine (Table 2) and a medication acquisition cost of $3005 (Table 3) compared to 260 days on risperidone with medication acquisition costs of $1878 (p <.01) and 239 days on quetiapine with medication acquisition costs of $1881 (p <.01).

The contributions to total direct medical costs were assessed for medication acquisition costs (stratified into controller medication and rescue medication), procedures (including laboratory tests, spirometry, and radiology), and hospital overheads (including personnel, administration costs, board, and lodging).

Low dose of quetiapine may explain its lower medication acquisition costs compared to olanzapine.

Even though the SPC patients had higher medication acquisition costs (US$479 vs. US$367), they accrued fewer clinic visits, laboratory tests, and electrocardiograms, thus translating into a reduction in comprehensive medical treatment costs over the 6 months of follow-up.

The customary unilateral focus on the cost of the index antipsychotic medication acquisition alone does not accurately reflect the incurred total costs of antipsychotic medications.

The majority of costs associated with medication acquisition (95.8%) and of procedures (89.6%) was generated during outpatient visits.

Based on high-user hospital pharmacy drug acquisition cost (2007; including 19% VAT), the difference in cost of medication is €608 in favor of L-AmB.